Cite
Noncanonical MAVS signaling restrains dendritic cell–driven antitumor immunity by inhibiting IL-12.
MLA
Wu, Lingling, et al. “Noncanonical MAVS Signaling Restrains Dendritic Cell–driven Antitumor Immunity by Inhibiting IL-12.” Science Immunology, vol. 8, no. 90, Dec. 2023, pp. 1–15. EBSCOhost, https://doi.org/10.1126/sciimmunol.adf4919.
APA
Wu, L., Hong, X., Yang, C., Yang, Y., Li, W., Lu, L., Cai, M., Cao, D., Zhuang, G., & Deng, L. (2023). Noncanonical MAVS signaling restrains dendritic cell–driven antitumor immunity by inhibiting IL-12. Science Immunology, 8(90), 1–15. https://doi.org/10.1126/sciimmunol.adf4919
Chicago
Wu, Lingling, Xiaochuan Hong, Chao Yang, Yuanqin Yang, Wenwen Li, Lu Lu, Meichun Cai, Dongqing Cao, Guanglei Zhuang, and Liufu Deng. 2023. “Noncanonical MAVS Signaling Restrains Dendritic Cell–driven Antitumor Immunity by Inhibiting IL-12.” Science Immunology 8 (90): 1–15. doi:10.1126/sciimmunol.adf4919.